PF-Atlas › Clinical Trials › NCT06057558
Airway Microbiome of Cystic Fibrosis Patients
Probiotic throat spray · Not specified
Registry ID
NCT06057558
Phase
Not specified
Status
Unknown
Drug / intervention
Probiotic throat spray
Sponsor
University Hospital, Antwerp
Start
2022-01-01
Enrollment
50
Locations
1
About this trial
With this study, the investigators first want to investigate the respiratory tract microbiome of cystic fibrosis patients. To achieve this, the investigators will collect longitudinal samples of saliva, throat and sputum and process these to determine the microbial composition and compare them over a timecourse of a year. Secondly, the investigators aim to study the influence of a topical microbiome therapy (throat spray) on the microbiome of the upper and lower respiratory tract in cystic fibrosis patients after administration for 6 weeks. Bacterial and cytokine profiles of salivary, throat and sputum samples will be monitored before, during and after intervention.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06057558 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.